13/02/2019Atypical ductal hyperplasia (ADH) is a breast lesion associated with a four- to five-fold increase in the risk of breast cancer. ADH is primarily found using mammography and identified on core needle biopsy. Despite multiple passes of the lesion during biopsy, only portions of the lesions are sampled.
07/01/2019A team of University of Illinois at Urbana-Champaign researchers led by Prof. Stephen Boppart has successfully visualized the tumor microenvironment of human breast tissue after it was surgically removed from a patient in the operating room by using a new portable optical imaging system. This work marks a major step toward providing cancer researchers with a tool for tracking tumor progression.
21/12/2018A team of University of Illinois at Urbana-Champaign researchers led by Professor Stephen Boppart has successfully visualized the tumor microenvironment of human breast tissue shortly after it was surgically removed from a patient in the operating room. The researchers achieved this using a new portable optical imaging system developed in Boppart's lab.
12/12/2018The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study.
10/12/2018A team of surgeons from the Perelman School of Medicine at the University of Pennsylvania are the first in the world to use a surgical robot to assist with a bilateral free flap breast reconstruction - a procedure in which tissue is taken from the lower abdomen and used to rebuild the breast. The robot allows surgeons to make a much smaller incision into the abdominal wall muscles.
03/12/2018Breast cancer survivors who used a smartphone app created at Houston Methodist consistently lost weight, largely due to daily, real-time interactions with their health care team via the mobile app. Few clinically-tested mobile apps exist today with clear measurable goals to support continued care of cancer survivors and patients.
29/11/2018Cryoablation-the destruction of cancer cells through freezing-shows early indications of effectiveness in treating women with low-risk breast cancers, according to research being presented today at the annual meeting of the Radiological Society of North America (RSNA). Researchers said that over the four years of the study, there has only been one case of cancer recurrence out of 180 patients.
01/03/2018Everyone is different. This statement also applies to our health. Cancer, in particular, can look and progress differently depending on the individual person. That’s why every patient ideally also needs a customized treatment that is tailored to their individual needs. But how feasible is this idea?